- Home
- HNRG vs FBRX Comparison
HNRG vs FBRX Comparison
Compare HNRG & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HNRG | FBRX |
|---|---|---|
| Founded | 1949 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 826.2M | 899.4M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HNRG | FBRX |
|---|---|---|
| Price | $15.24 | $54.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $25.38 | ★ $67.00 |
| AVG Volume (30 Days) | 703.6K | ★ 959.3K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 116.78 | 61.30 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $469,466,000.00 | $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.09 | N/A |
| 52 Week Low | $14.68 | $9.25 |
| 52 Week High | $24.70 | $62.46 |
Technical Indicators
Market Signals| Indicator | HNRG | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 77.50 |
| Support Level | $15.22 | $24.72 |
| Resistance Level | $20.08 | N/A |
| Average True Range (ATR) | 0.78 | 6.08 |
| MACD | -0.05 | 2.06 |
| Stochastic Oscillator | 0.46 | 83.31 |
Price Performance
Historical ComparisonAbout HNRG Hallador Energy Company
Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.